BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8590157)

  • 1. Monitoring of lectin-reactive alpha-fetoproteins in patients with hepatocellular carcinoma treated using transcatheter arterial embolization.
    Yamashita F; Tanaka M; Satomura S; Tanikawa K
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):627-33. PubMed ID: 8590157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of alpha-fetoprotein messenger RNA for early detection of recurrent hepatocellular carcinoma: a prospective pilot study.
    Schmilovitz-Weiss H; Stemmer SM; Liberzon E; Avigad S; Sulkes J; Belinki A; Kazatsker A; Ben-Ari Z
    Cancer Detect Prev; 2006; 30(2):204-9. PubMed ID: 16638626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of transcatheter arterial embolization in terms of serum alpha-fetoprotein doubling time in hepatocellular carcinoma].
    Kanno T; Harihara S; Kim K; Kimura S; Tamori A; Kuroki T; Mizoguchi Y; Kobayashi K; Monna T; Nakamura K
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):683-7. PubMed ID: 2451472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of measurement of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and recurrence of small hepatocellular carcinoma.
    Hayashi K; Kumada T; Nakano S; Takeda I; Sugiyama K; Kiriyama S; Sone Y; Miyata A; Shimizu H; Satomura S
    Am J Gastroenterol; 1999 Oct; 94(10):3028-33. PubMed ID: 10520864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective prognostic impact of serum alpha-fetoprotein level in patients with hepatocellular carcinoma: analysis of 543 patients in a single center.
    Huo TI; Huang YH; Lui WY; Wu JC; Lee PC; Chang FY; Lee SD
    Oncol Rep; 2004 Feb; 11(2):543-50. PubMed ID: 14719097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of DC beads in hepatocellular carcinoma: clinical and radiological results of a drug delivery device for transcatheter superselective arterial embolization.
    Sadick M; Haas S; Loehr M; Elshwi M; Singer MV; Brade J; Schoenberg SO; Diehl SJ
    Onkologie; 2010; 33(1-2):31-7. PubMed ID: 20164659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors.
    Ueno K; Miyazono N; Inoue H; Nishida H; Kanetsuki I; Nakajo M
    Cancer; 2000 Apr; 88(7):1574-81. PubMed ID: 10738215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan.
    Kawai S; Tani M; Okamura J; Ogawa M; Ohashi Y; Monden M; Hayashi S; Inoue J; Kawarada Y; Kusano M; Kubo Y; Kuroda C; Sakata Y; Shimamura Y; Jinno K; Takahashi A; Takayasu K; Tamura K; Nagasue N; Nakanishi Y; Makino M; Masuzawa M; Yumoto Y; Mori T; Oda T
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-38-S6-45. PubMed ID: 9151915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoembolization for primary liver cancer.
    Achenbach T; Seifert JK; Pitton MB; Schunk K; Junginger T
    Eur J Surg Oncol; 2002 Feb; 28(1):37-41. PubMed ID: 11869011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between Lens culinaris agglutinin-reactive alpha-fetoprotein and pathologic features of hepatocellular carcinoma.
    Tada T; Kumada T; Toyoda H; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kitabatake S; Kuzuya T; Nonogaki K; Shimizu J; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J; Satomura S
    Liver Int; 2005 Aug; 25(4):848-53. PubMed ID: 15998436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of tumor pressure as a prognostic factor in cases of hepatocellular carcinoma where the diameter of the tumor is 3 cm or less.
    Ueki T; Sakaguchi S; Miyajima Y; Hatono N; Tohara K; Nakabayashi S; Yao T; Kokawa H; Hirano M; Okumura M
    Cancer; 2002 Aug; 95(3):596-604. PubMed ID: 12209753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with survival exceeding 5 years after transcatheter arterial embolization for hepatocellular carcinoma.
    Yoshioka H; Sato M; Sonomura T; Terada M; Kishi K; Yoshikawa A
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-29-S6-37. PubMed ID: 9151914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Levels of serum alpha-fetoprotein before and after transcatheter embolization of hepatocellular tumors with Lipiodol].
    Mlinarić B
    Lijec Vjesn; 2000; 122(1-2):6-8. PubMed ID: 10916349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The clinical course of nodular type hepatocellular carcinomas after transcatheter arterial embolization (TAE) therapy].
    Suyama Y; Kitagawa Y; Horishi M; Shizumi Y; Yashige H; Fujii H; Miyoshi M
    Gan No Rinsho; 1989 Aug; 35(9):983-9. PubMed ID: 2475651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for death in 224 cases of hepatocellular carcinoma after transcatheter arterial chemoembolization.
    Hiraoka A; Horiike N; Yamashita Y; Koizumi Y; Doi H; Yamamoto Y; Ichikawa S; Hasebe A; Yano M; Miyamoto Y; Ninomiya T; Ootani H; Takamura K; Kawasaki H; Otomi Y; Kogame M; Sogabe I; Ishimaru Y; Kashihara K; Miyagawa M; Hirooka M; Hiasa Y; Matsuura B; Michitaka K; Onji M
    Hepatogastroenterology; 2009; 56(89):213-7. PubMed ID: 19453060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in resected hepatocellular carcinomas and therapeutic value of transcatheter arterial embolization for recurrences.
    Kimura H; Yabushita K; Konishi K; Maeda K; Kuroda Y; Tsuji M; Demachi H; Miwa A
    Int Surg; 1998; 83(2):146-9. PubMed ID: 9851333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter arterial chemoembolization (TACE) in treatment of hepatocellular carcinoma.
    Barone M; Ettorre GC; Ladisa R; Schiavariello M; Santoro C; Francioso G; Vinciguerra V; Francavilla A
    Hepatogastroenterology; 2003; 50(49):183-7. PubMed ID: 12630019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of transcatheter arterial embolization and percutaneous ethanol injection for hepatocellular carcinoma: comparison of efficacies of doxorubicin and epirubicin in transcatheter arterial embolization.
    Nakamura S; Tanaka K
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-46-S6-49. PubMed ID: 9151916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma.
    Aoyagi Y; Oguro M; Yanagi M; Mita Y; Suda T; Suzuki Y; Hata K; Ichii K; Asakura H
    Cancer; 1996 May; 77(9):1781-6. PubMed ID: 8646674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.